Steven Engle

Steven Engle holds deep experience in US capital markets, a record of achievement with big pharma partnering and established links with the US FDA. As a former CEO of NASDAQ-listed companies Xoma and La Jolla Pharmaceuticals, he brings wide networks in the US and European biotech industries. He is a current CEO of Averigon Consulting, a leading advisory firm to the US life sciences industry. Mr Engle is also the Non-Executive Chairman of Prescient Therapeutics.
Bio last updated 02 Dec 2015

Positions - Current

PositionCompanyYearCompany's current rankWA staff
Non-Executive Chairman
Prescient Therapeutics
Prescient Therapeutics

Directors Interests

CompanyDateTransaction typeNumber of sharesPrice per shareTransaction valueNature of change
Prescient Therapeutics23 Nov 2015Issued300,000$0.00OtherIssue of options

Directors Shareholdings

CompanyDirect sharesIndirect sharesTotal sharesTotal value
Prescient Therapeutics0$0

Equity Capital Markets Deals

DateCompanyTransaction TypeTotal Value
30/06/16Prescient TherapeuticsEntitlement offer$3.4m>>


Non-Executive Chairman
Year started and most recent title

BNiQ Disclaimer